17 research outputs found
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy
Mutant Oncopeptide Immunization Induces CTL Specifically Lysing Tumor Cells Endogenously Expressing the Corresponding Intact Mutant p53
Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons
Novel Substituent Orientation in Reimer-Tiemann Reactions of Pyrrole-2-carboxylates
Reimer-Tiemann formylation reactions (base/CHCl3) on 5-substituted pyrrole-2-carboxylates (1, 6, 8, 9, 11, and 13) afford 2-formylpyrroles (5, 7, 10, 12, and 14) in which the formyl group is situated in the position originally occupied by the carboxylate function, and not, as had been expected, in the 5-unsubstituted site. These observations are confirmed by X-ray crystal structures of compounds 5, 7, and 10 and by nuclear Overhauser enhancement experiments for pyrroles 7, 10, and 14. © 1985, American Chemical Society. All rights reserved
Recombinant Modified Vaccinia Virus Ankara (MVA) Expressing Wild-Type Human p53 Induces Specific Antitumor CTL Expansion
Progress on new vaccine strategies for the immunotherapy and prevention of cancer
In recent years, great strides in understanding and regulating the immune system have led to new hope for harnessing its exquisite specificity to destroy cancer cells without affecting normal tissues. This review examines the fundamental immunologic advances and the novel vaccine strategies arising from these advances, as well as the early clinical trials studying new approaches to treat or prevent cancer